Raymond James Maintains Strong Buy on Tenet Healthcare, Raises Price Target to $175
Portfolio Pulse from Benzinga Newsdesk
Raymond James analyst John Ransom has maintained a Strong Buy rating on Tenet Healthcare (NYSE:THC) and raised the price target from $130 to $175.
July 25, 2024 | 5:14 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Raymond James analyst John Ransom has maintained a Strong Buy rating on Tenet Healthcare and raised the price target from $130 to $175.
The Strong Buy rating and significant increase in the price target from $130 to $175 by a reputable analyst at Raymond James is likely to positively impact investor sentiment and drive the stock price up in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100